Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronjon Chakraverty

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|January 9, 2013
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemiaSimon E Richardson, Iftekhar Khan, Andrew Rawstron, et al.
Eclinicalmedicine|June 13, 2025
Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus studySarah E Hughes, Foram Khatsuria, Christel McMullan, et al.
Haematologica|November 2, 2020
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft functionMaria M Cuadrado, Richard M Szydlo, Mike Watts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin LymphomaYasmin Reyal, Irfan Kayani, Adrian J C Bloor, et al.
Blood|May 31, 2002
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitutionSuparno Chakrabarti, Stephen Mackinnon, Raj Chopra, et al.
JCI Insight|March 9, 2018
Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host diseasePedro Santos E Sousa, Séverine Ciré, Thomas Conlan, et al.
Blood|December 28, 2017
Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiencyThomas A Fox, Ronjon Chakraverty, Siobhan Burns, et al.
Blood|July 1, 2010
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitutionRonjon Chakraverty, Guillermo Orti, Michael Roughton, et al.
Science Translational Medicine|April 3, 2015
G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host diseaseMaud D'Aveni, Julien Rossignol, Tereza Coman, et al.
Science Translational Medicine|November 17, 2017
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulationAntonio Galleu, Yanira Riffo-Vasquez, Cristina Trento, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|January 9, 2013
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemiaSimon E Richardson, Iftekhar Khan, Andrew Rawstron, et al.
Eclinicalmedicine|June 13, 2025
Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus studySarah E Hughes, Foram Khatsuria, Christel McMullan, et al.
Haematologica|November 2, 2020
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft functionMaria M Cuadrado, Richard M Szydlo, Mike Watts, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2016
Impact of Pretransplantation (18)F-Fluorodeoxyglucose-Positron Emission Tomography on Survival Outcomes after T Cell-Depleted Allogeneic Transplantation for Hodgkin LymphomaYasmin Reyal, Irfan Kayani, Adrian J C Bloor, et al.
Blood|May 31, 2002
High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitutionSuparno Chakrabarti, Stephen Mackinnon, Raj Chopra, et al.
JCI Insight|March 9, 2018
Peripheral tissues reprogram CD8+ T cells for pathogenicity during graft-versus-host diseasePedro Santos E Sousa, Séverine Ciré, Thomas Conlan, et al.
Blood|December 28, 2017
Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiencyThomas A Fox, Ronjon Chakraverty, Siobhan Burns, et al.
Blood|July 1, 2010
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitutionRonjon Chakraverty, Guillermo Orti, Michael Roughton, et al.
Science Translational Medicine|April 3, 2015
G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host diseaseMaud D'Aveni, Julien Rossignol, Tereza Coman, et al.
Science Translational Medicine|November 17, 2017
Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulationAntonio Galleu, Yanira Riffo-Vasquez, Cristina Trento, et al.
Pageof 8